Professor of Medicine, Lyon University, Institut Universitaire de France // Medical Director, Hepatology Department at the Hospices Civils de Lyon, France // Scientific Director, Viral Hepatitis Research Laboratory, INSERM U1052, Cancer Research Center of Lyon, France
Institution: Lyon University and INSERM
Biography of Fabien ZOULIM
Fabien Zoulim obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He is Professor of Medicine at Lyon I University since 1997. He is currently Medical Director of the Hepatology Department at the Hospices Civils de Lyon, and Scientific Director of the Department of Immunology and Virology of INSERM Unit 1052 where he is leading the team on ‘Antiviral therapy of viral hepatitis’. Dr Zoulim has served as an Associate Editor for Journal of Hepatology and is currently Associate Editor for Gut. He also served as an expert in the microbiology study section of the INSERM and as head of the clinical viral hepatitis study section at ANRS. He served as a Governing Board member of the European Association for the Study of the Liver (EASL). Dr Zoulim received the William Prusoff award of the International Society for Antiviral Research. He has been the scientific coordinator of a European Community-funded Network of Excellence on the management of antiviral drug resistance. He is currently coordinating the ANRS “HBV cure” program in France and the IP-cure-B project within the EU H2020 workprogram. He co-founded the International Coalition to Eliminate HBV (ICE-HBV: http//:www.ice-hbv.org). Fabien Zoulim is a recognized expert in the field of viral hepatitis and antiviral therapy, and has published more than 400 articles (H index 75, Web of Science).